Cargando…

Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition

Chronic inflammation has been associated with a variety of human cancers including prostate cancer. Interleukin-17 (IL-17) is a critical pro-inflammatory cytokine, which has been demonstrated to promote development of prostate cancer, colon cancer, skin cancer, breast cancer, lung cancer, and pancre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Q, Liu, S, Parajuli, KR, Zhang, W, Zhang, K, Mo, Z, Liu, J, Chen, Z, Yang, S, Wang, AR, Myers, L, You, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213194/ https://www.ncbi.nlm.nih.gov/pubmed/27375020 http://dx.doi.org/10.1038/onc.2016.240

Ejemplares similares

Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition
por: Seol, Min A., et al.
Publicado: (2019)

Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9
por: Yang, Feilong, et al.
Publicado: (2018)

Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis
por: Xu, Q, et al.
Publicado: (2016)

TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9
por: Chen, Sui, et al.
Publicado: (2021)

Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
por: Li, Yuanchun, et al.
Publicado: (2020)

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)

MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer
por: Zhang, Tianbiao, et al.
Publicado: (2020)

Keratin 17 Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Pancreatic Cancer
por: Zeng, Yong, et al.
Publicado: (2020)

Parathyroid Hormone Related-Protein Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer
por: Ongkeko, Weg M., et al.
Publicado: (2014)

Interleukin 17A promotes gallbladder cancer invasiveness via ERK/NF-κB signal pathway mediated epithelial-to-mesenchymal transition
por: Chen, Kunlun, et al.
Publicado: (2020)

Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure
por: Wang, Y., et al.
Publicado: (2014)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Interleukin-17 enhances immunosuppression by mesenchymal stem cells
por: Han, X, et al.
Publicado: (2014)

Knockdown of BAG3 induces epithelial–mesenchymal transition in thyroid cancer cells through ZEB1 activation
por: Meng, X, et al.
Publicado: (2014)

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
por: Xie, G, et al.
Publicado: (2014)

Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/syndecan-1/TGF-β autocrine loop
por: Zeng, Ye, et al.
Publicado: (2016)

High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression
por: Ling, Li, et al.
Publicado: (2018)

Interleukin-8 drives epithelial-mesenchymal transition of human carcinomas
por: Fernando, Romaine I, et al.
Publicado: (2013)

Epithelial-mesenchymal transition in prostate cancer: an overview
por: Montanari, Micaela, et al.
Publicado: (2017)

Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
por: Yu, Dinglai, et al.
Publicado: (2017)

Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells
por: Li, Chuan-Hong, et al.
Publicado: (2022)

Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition
por: Zhang, Wenxue, et al.
Publicado: (2017)

Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer
por: Ding, Chenbo, et al.
Publicado: (2016)

IL-17A and GDF15 are able to induce epithelial-mesenchymal transition of lung epithelial cells in response to cigarette smoke
por: Jiang, Gang, et al.
Publicado: (2018)

miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway
por: Zhu, Z, et al.
Publicado: (2015)

Interleukin-6 induces epithelial-mesenchymal transition in human intrahepatic biliary epithelial cells
por: JIANG, GUI-XING, et al.
Publicado: (2016)

Correction to “Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells”
por: Li, Chuan-Hong, et al.
Publicado: (2023)

MicroRNA-4287 is a novel tumor suppressor microRNA controlling epithelial-to mesenchymal transition in prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
por: Di Zazzo, Erika, et al.
Publicado: (2019)

Epithelial-Mesenchymal Transition in tumor microenvironment
por: Jing, Yingying, et al.
Publicado: (2011)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
por: Bernaudo, S, et al.
Publicado: (2016)

An electrochemical biosensor for the detection of epithelial-mesenchymal transition
por: Du, Xin, et al.
Publicado: (2020)

Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells
por: Qi, Shasha, et al.
Publicado: (2018)

LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer
por: Liu, Y-w, et al.
Publicado: (2015)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020)

WFDC2 contributes to epithelial–mesenchymal transition (EMT) by activating AKT signaling pathway and regulating MMP-2 expression
por: Chen, Yao, et al.
Publicado: (2019)

Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor
por: Liu, Sen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nl35ec16k7uaotlp7a3fr2iod0